-
1.
公开(公告)号:US20160257964A1
公开(公告)日:2016-09-08
申请号:US15069057
申请日:2016-03-14
Applicant: Intrexon Corporation
Inventor: Subba Reddy PALLI , Mohan Basavaraju Kumar , Dean Ervin Cress , Ted Tsutomu Fujimoto
CPC classification number: C12N15/635 , C07K14/70567 , C07K14/721 , C12N7/00 , C12N15/86 , C12N2710/10043 , C12P21/02
Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to novel substitution mutant receptors and their use in a Group H nuclear receptor-based inducible gene expression system and methods of modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms.
-
公开(公告)号:US10190124B2
公开(公告)日:2019-01-29
申请号:US15069057
申请日:2016-03-14
Applicant: Intrexon Corporation
Inventor: Subba Reddy Palli , Mohan Basavaraju Kumar , Dean Ervin Cress , Ted Tsutomu Fujimoto
Abstract: This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to novel substitution mutant receptors and their use in a Group H nuclear receptor-based inducible gene expression system and methods of modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms.
-